Cargando…
PD-1 blockage combined with vaccine therapy can facilitate immune infiltration in tumor microenvironment of Lynch syndrome colon cancer
Background: Lynch syndrome is a genetic disease resulting from mismatch repair gene mutation. Vaccine therapy can enhance the immunogenicity of Lynch syndrome and improve the therapeutic efficacy of immunotherapy. However, there is no approved Lynch syndrome vaccine coming onto the market. Methods:...
Autores principales: | Ye, Kai, Zhong, Wenjin, Wang, Pengcheng, Chen, Yanxin, Chi, Pan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493022/ https://www.ncbi.nlm.nih.gov/pubmed/36160005 http://dx.doi.org/10.3389/fgene.2022.877833 |
Ejemplares similares
-
Comparison of Molecular, Clinicopathological, and Pedigree Differences Between Lynch-Like and Lynch Syndromes
por: Xu, Yun, et al.
Publicado: (2020) -
Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer
por: Wang, Changjing, et al.
Publicado: (2022) -
DNA methylation regulator-mediated modification pattern defines tumor microenvironment immune infiltration landscape in colon cancer
por: Yuan, Shijin, et al.
Publicado: (2022) -
The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma
por: He, Wan, et al.
Publicado: (2022) -
The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
por: Wang, Xueping, et al.
Publicado: (2020)